generate the silica precursor and initiate the silica growth, 1 µl of tetramethoxysilane was added to the solution. The mixture was shaken overnight, and the suspended particles were collected by centrifugation (5 min at 14000 rpm), washed with deionized water a few times and dried in vacuum overnight on a coverslide. To remove the organic compounds, a coverslide carrying the nanoparticle powder was placed over a hot plate and calcined overnight at 450°C. The calcined powder was transferred to a tube and suspended in 50 µl water and dispersed by gentle sonication.
Preparation of Synthetic Hollow Enzyme Loaded Nanospheres (SHELS):
The same protocol was used for encapsulation of both penicillinase, Renilla reniformis luciferase, and Elspar within SHELS. 4 µl of 10 mg/ml enzyme solution was added to a 50 µl SHMS solution and incubated overnight. The solution was diluted with 1000 µl S3 phosphate buffered saline and 50 µl 0.1% poly-L-lysine with a molecular weight of 150-300 kDa. Solution is diluted to prevent aggregation and encapsulated enzyme does not seem to leak out rapidly to cause a significant difference in loading when compared with the undiluted reaction (data not shown). TMOS was added to 1 mM HCl in 74:500 volume ratio and mixed for a few minutes to make a silicic acid solution. 25 µl of the silicic acid solution was added to the above SHMS solution immediately after dilution and shaken for 1 hour in order to generate SHELS. Later, suspended SHELS were collected with centrifugation (5 min 14000 rpm) and washed several times with water. Samples were exposed to proteinase-K enzyme overnight at a concentration of 0.1 mg/ml in 1X phosphate buffered saline (PBS) solution at 37°C followed by removal of proteinase-K by successive washing again by 1X PBS by centrifugation (5 min 14000 rpm).
Preparation of Silica Hollow Nanospheres (SHS):
Similar protocol as the fabrication of SHMS was followed except omitting nanomask addition to the reaction.
Functionalization of SHELS with polyethylene glycol (PEG): A suspension of SHELS
(~4x10 12 particles/ml) in 1X PBS is mixed with equal volume of aqueous solution of 10 mg/ml PEG-silane and mixed overnight in room temperature. Later, suspended PEGylated SHELS were collected with centrifugation (5 min 14000 rpm) and washed several times with water.
Labeling Penicillinase with Cy5: Cy5 maleimide is used as labeling agent for this protocol. 1 mg penicillinase was dissolved in 100 µl degassed PBS buffer at 10 mg/ml concentration. It is recommended to carry out thiol modifications in under nitrogen in degassed solvents/buffers. The solution was left at room temperature for around 30 S4 minutes. About 100 molar excess of TCEP was added to the solution. The vial was flushed with nitrogen gas, capped and mixed thoroughly. This reaction was incubated at room temperature for 10 minutes. 100 µg Cy5 maleimide was dissolved in 2 µl DMF and added to the enzyme solution. The vial was again flushed with nitrogen, capped and mixed thoroughly. This solution was incubated at room temperature for two hours while being mixed every 30 minutes. Finally, the reaction was left overnight at 2-8°C. Later, unbound dye was removed by a desalting column with a molecular weight cut-off at 7 kDa.
Labeling Asparaginase with Cy5: A protocol similar to penicillinase labeling was followed for labeling of asparaginase.
Measurement of Activity of Penicillinase with CCF2:
The activity is measured in 100% normal mouse serum as the initial rate of increase of the ratio of blue fluorescence (447 nm) to green fluorescence (520 nm) with excitation at 409 nm.
Measurement of Entrapment Capacity:
The amount of Cy5 labeled penicillinase and asparaginase were detected by measuring fluorescence intensity at 620 nm excitation and 665 nm emission. The enzyme amounts were estimated based on associated standard curves. Activity of penicillinase and asparaginase were validated with nitrocefin and Nessler's assays respectively.
Nitrocefin Assay for Measurement of Penicillinase Activity: For colorimetric determination of penicillinase activity, 100 µL enzyme solutions were transferred onto a 96-well microtiter plate. One hundred microliters nitrocefin working solution were added into each well. One milligram nitrocefin was dissolved in 100 µL DMSO, and 1.9 mL S5 phosphate buffer were added to obtain the working solution. Absorbance at 492 nm was measured at 37°C on a Tecan (Switzerland) Infinite 200 PRO Plate reader.
Nessler's Assay for Measurement of Asparaginase Activity: 100 ul of asparaginase and asparagine solution was reacted at 37°C followed by stopping with 100 ul of 5% trichloro acetic acid. 20 ul of Nessler's reagent was added to each reaction.at 5 min and absorbance at 492 nm was measured at 37°C on a Tecan (Switzerland) Infinite 200 PRO Plate reader. Enzyme activity was quantified based on the standard curve of ammonia obtained by Nessler's reagent.
Measurement of Antibody Binding:
Anti-penicillinase was functionalized with biotin groups. Alexa 488 dye with streptavidin was added to all samples followed by successive washing. Fluorescence intensity measurements performed at 480 nm excitation and 530 nm emission.
Measurement of in vivo
Activity: BALB/c mice were used for the study. 5 mice were injected with 100 µl of Gaussia princeps luciferase (GaLuc) enzyme encapsulated SHELS solution intramuscularly. SHELS were suspended in 1X phosphate buffered saline (PBS) with a concentration of ~4x10 12 particles/ml. 150 µg native-coelenterazine was administered intravenously in the lateral tail vein of each mouse. 10 µg benzylcoelenterazine was dissolved in 95% ethanol and diluted with 1X PBS to 10% final concentration of alcohol. Mice were anesthetized by isoflurane and luminescence intensity was measured intravenous injections with an exposure of 2 seconds. Similar luminescence intensities were measured from each mouse and and reading from one of the mice is reported in the text.
S6
Immunization of mice: 5 Balb/C mice was injected subcutaneously with 20 µg of penicillinase dispersed in 50 ul of 1X phosphate buffered saline on days 0, 14 and 28.
Blood was collected via retro-orbital bleed. ~100 µl Blood was collected on day 42 and processed to serum by centrifugation at 4°C and 1600rpm for 8 minutes, snap frozen in dry ice and stored at -80°C until the experiment. For the experiments all serum samples was pooled from 5 mice.
Cy7 labeling of SHMS:
An aqueous suspension of SHMS solution with a concentration of ~4x10 12 particles/ml is incubated with 1 µl of >97% (3-aminopropyl)trimethoxysilane (APTMS) for 12 hours at room temperature followed by collection of the suspended particles with centrifugation (5 min at 14000 rpm) and successive washing with water in order to remove unbound APTMS. Later the pellet was suspended in 200 µl of phosphate buffer at pH 8. 67 µg of Cy7 NHS ester was dissolved in 20 ul dimethylsulfoxide and added into SHMS solution.
The solution was mixed for 12 hours followed by removal of unbound dye by successive washing as described above. Loading and sealing of labeled SHMS were performed with a procedure similar to that used for unlabeled SHMS. 
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